Tamiflu, Vioxx Pediatric Adverse Event Reports To Be Presented At Committee Meeting
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Pediatric Advisory Committee will also hear pediatric adverse event reports on Agrylin, Paraplatin, Diflucan, Camptosar, Ferrlecit and Imitrex at Nov. 18 meeting.